Cashu FinanceCashu Finance
  • Terminal
  • Spotlight
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. MDWD

Market Cap: $156.34M

ML

MediWound Ltd.

MDWD
NASDAQUSD
Purchase MDWD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

–
–(–)

Open

$15.16

Prev. Close

$12.00

High

$15.16

Low

$14.65

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

CEOOfer Gonen
SectorHealthcare

Recently from Cashu

MediWound Reports Significant Revenue Growth and Improved Profitability in Advanced Wound Care

### MediWound’s Strategic Growth in Advanced Wound Care Solutions MediWound, a company specializing in advanced wound care solutions, showcases noteworthy progress in its latest earnings report for th…

Cashu Finance·8 months ago

MediWound Reports Strong Q4 Growth and Strategic Expansion in Advanced Wound Care Sector

MediWound's Strategic Growth in Advanced Wound Care Solutions MediWound (NASDAQ: MDWD) showcases impressive growth in its latest financial results for the fourth quarter, emphasizing the company's com…

Cashu Finance·8 months ago

MediWound Reports Strong Q4 Growth, Signaling Promising Future in Advanced Wound Care Market

MediWound Posts Strong Q4 Results, Signaling Growth in Advanced Wound Care MediWound (NASDAQ: MDWD) presents a promising outlook in its latest Q4 earnings report, showcasing substantial growth driven…

Cashu Finance·8 months ago

MediWound's Strategic Positioning for Growth in Advanced Wound Care Solutions

MediWound's Strategic Positioning Amid Industry Dynamics MediWound, a leader in advanced wound care solutions, faces a critical moment as the healthcare industry continues to evolve. The company speci…

Cashu Finance·11 months ago
Industry
Biotechnology
Employees121
IPO DateMar 20, 2014
ExchangeNASDAQ
Exchange NameNASDAQ
CurrencyUSD
Headquarters & Contact
Address42 Hayarkon Street
City / State / ZIPYavne, HM, 8122745
CountryIsrael
Phone972 7 797 14100
Websitehttps://www.mediwound.com